Research · 1 November 2026
Exin Therapeutics uses AI agent to inject gene therapy into live mouse brain
Exin Therapeutics CEO Gabriel Ocana Santero deployed an AI agent with a robotic arm to select a gene therapy and perform a brain injection on a live mouse, illustrating autonomous lab experimentation.
Why it matters
Consider piloting AI‑driven experimental pipelines; the autonomous injection shows a path to faster preclinical testing.
For product managers
For your product
What does this mean for your product?
Try it on your product More from this issueAll AI news from 1 Nov →
Get this every morning, written for your product.
Deltaday reads the whole AI news cycle and tells you what changed, whether it's real yet, and what to do about it.